In contrast, knockdown of USP8 promotes ASCL1 ubiquitination and its degradation in hBMSCs [54], indicating that USP8 inhibitors may play a candidate role in SCLC-A tumorigenesis. Here, USP8 is linked to small cell lung carcinoma.